Golden
11.2 Capital

11.2 Capital

A venture capital and private equity firm focused on emerging technologies in artificial intelligence, cybersecurity, robotics, quantum, new space, computational therapeutics and synthetic biology.

11.2 Capital is a venture capital and private equity firm focused on emerging technologies in artificial intelligence, cybersecurity, robotics, quantum, new space, computational therapeutics and synthetic biology that is headquartered in San Francisco, California and was founded in 2014 by Shelley Zhuang. The firm specializes in offering its early stage companies several services such as technical recruiting, partnerships, customer introductions, and follow-on financing. 



Notable investments made by 11.2 Capital include: TigerGraph, WhiteOps, Avaamo, Ginkgo Bioworks, Forter, Aunransa, Bay Labs, Cruise, Vertical, Notable Labs, Savioke, Molecular Assemblies, Kindred, Deep Genomics, and Lucira Health. 

Timeline

Funded Companies

Company
Description
Website
Industry
Location

Synthace is a software company based out of London, UK building automation software that gives biologists the ability to control and analyze the performance of lab hardware.

5 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References